Micron Sees AIDriven Memory Demand Surging as Company Expands Singapore Operations Wall Street Journals Heard on the Street Unveils 8th Annual StockPicking Contest QLine Biotech IPO Allotment Expected Today Grey Market Premium at 115 Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales and Item Volume Bessent Sees Substantial Disinflation Ahead as Warsh Assumes Fed Leadership Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch MTA Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Broader Sentiment RITM Q1 2026 Earnings Modest EPS Beat Highlights Steady Portfolio Performance FGSN Q1 2026 Earnings Earnings Miss Sends Notes Lower AMN Healthcare Q1 2026 Earnings Strong EPS Beat Drives Stock Surge World Kinect Corporation WKC Q1 2026 Earnings Massive EPS Beat Drives Shares Higher NewtekOne Inc NEWTI Q1 2026 Earnings EPS Slightly Misses Expectations Bond Price Unchanged Marwynn Holdings MWYN Holds Steady Near 088 as Traders Eye Key Support and Resistance Levels Xtant Medical Holdings Holds Near Key Resistance Level After Modest Gain Acumen Pharmaceuticals ABOS Edges Higher Amid Low Volume Tests Key Resistance Levels Genesco Inc GCO Surges 37 as Footwear Retailer Tests Resistance at 3887 BrightSpire Capital BRSP Holds Steady at 568 as Trading Range Tightens SP Global SPGI Dividend Appeal Highlighted as Mobility SpinOff Approaches zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent M Evo Global Acquisition Corp II MEVOU Units Hold at 101 Support and Resistance Levels Define Trading Range Southern First Bancshares SFST Edges Higher as Stock Consolidates Near Resistance Old National Bancorp Preferred Shares ONBPO Hold Steady Near Support Levels ZoomInfo Technologies GTM Slides to 35 as Selling Pressure Intensifies John Hancock Income Securities Trust JHS Holds Steady at 1102 Amid RangeBound Trading Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 Jaguar Health JAGX Surges 687 as Shares Test Critical Resistance at 327 Aytu BioPharma Rallies as Shares Test Key Resistance Levels